glp 1 semaglutide or tirzepatide & are transforming diabetes & obesity management. These GLP-1 receptor agonists offer benefits from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from GLP-1 medications are marketed to

The goal is to stop before you feel overly full, not to clean the plate because the plate is there

The Semaglutide Story: Highlighting the Need to Maintain Patent Protection in Canada Semaglutide, the blockbuster GLP-1 receptor agonist marketed under names like Ozempic (type 2 diabetes) and Wegovy (weight loss), has rapidly become one of the most consequential drugs in modern healthcare

Patients' Preferences for OnceDaily Oral Versus OnceWeekly Injectable Diabetes Medications: The REVISE Study

Both medications contain the active ingredient which also mimic the naturally occurring gastrointestinal hormone GLP-1 but also mimics the GI hormone gastric inhibitory peptide (GIP)

As you lose weight, your body is under real physiological stress